(Part #2) You Raised Prices. Demand Is Softening. Now What?
Recap In Part 1 of this series, we suggested 5 potential focus areas for companies facing softening demand. This broader lens applies whether they have taken recent price increases, are considering new ones, or simply asking “Now what?” Here’s the list: Understand your current margin profile(s) and the relationship to your pricing stance Rebalance pricing […]
Charging For Return Shipping: Legitimate Value-Based Pricing Strategy
An often overlooked tool for pricing segmentation is ripe for a comeback: charging return shipping fees. It is a worthy tool in the pricing strategy toolset that brands must employ in this challenging environment. Footwear News is reporting on the increased uptake of this strategy among well-respected brands. While in the go-go times of no […]
You Raised Prices. Demand Is Softening. Now What?
The Bull Market for Pricing Actions: Is It Over? That bubble-burstin’ feeling. It’s been a bull market (with some bubble symptoms) for price increases. Some were thoughtfully and strategically done. Others were rushed, me-too, fear-of-missing-out (FOMO) affairs. Whether brands did one or the other or something in between, we’re not here to judge. A lot […]
Footwear Pricing Strategy: Who Will “Just Do It”?
Part 1: Will Footwear Brands Raise Prices In 2022? Many footwear brands have signaled intent to raise prices in 2022, and a select few have reported already doing so in 2021. But what does this tell us about footwear pricing strategy moves in 2022? For now, a survey of earnings reports and retail pricing on […]
Grocery Prices Inflation: Cub Foods – A Poor Value?
Cub Foods is priced 60%+ higher than key competitors Many people may be noticing higher grocery bills from their average store trips over the last year, and chalk it up to inflation. True, inflation plays a role. But it turns out that where you shop matters a lot more than whether inflation is 2% or […]
Hope Is Not A Strategy: Drug Prices Impact On Medicare & Taxpayers
Introduction Lately, my LinkedIn feed has been persistently featuring this Alzheimer’s Association post. It calls for everyone to protest the draft decision by CMS (Centers for Medicare & Medicaid Services) to limit coverage for the Alzheimer’s drug, Aduhelm, hoping for an ultimate reversal. Nearly all of us, me included, have loved ones with Alzheimer’s. Even […]
